AmiCa: Atlas of MiRNA-gene Correlations in Cancer

Overview

Journal Comput Struct Biotechnol J

Specialty Biotechnology

Date 2024 Jun 6

PMID 38840833

Authors

Nina Hauptman

Joze Pizem

Dasa Jevsinek Skok

Affiliations

Soon will be listed here.

Abstract

The increasing availability of RNA sequencing data has opened up numerous opportunities to analyze various RNA interactions, including microRNA-target interactions (MTIs). In response to the necessity for a specialized tool to study MTIs in cancer and normal tissues, we developed AmiCa (https://amica.omics.si/), a web server designed for comprehensive analysis of mature microRNA (miRNA) and gene expression in 32 cancer types. Data from 9498 tumor samples and 626 normal samples from The Cancer Genome Atlas were obtained through the Genomic Data Commons and used to calculate differential expression and miRNA-target gene (MTI) correlations. AmiCa provides data on differential expression of miRNAs/genes for cancers for which normal tissue samples were available. In addition, the server calculates and presents correlations separately for tumor and normal samples for cancers for which normal samples are available. Furthermore, it enables the exploration of miRNA/gene expression in all cancer types with different miRNA/gene expression. In addition, AmiCa includes a ranking system for genes and miRNAs that can be used to identify those that are particularly highly expressed in certain cancers compared to other cancers, facilitating targeted and cancer-specific research. Finally, the functionality of AmiCa is illustrated by two case studies.

Citing Articles

Upregulation of Differentiates Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma and Both Colorectal and Pancreatic Adenocarcinoma Liver Metastases.

Draskovic T, Rankovic B, Zidar N, Hauptman N Genes (Basel). 2025; 15(12.

PMID: 39766812 PMC: 11675665. DOI: 10.3390/genes15121545.

References

Keller A, Groger L, Tschernig T, Solomon J, Laham O, Schaum N . miRNATissueAtlas2: an update to the human miRNA tissue atlas. Nucleic Acids Res. 2021; 50(D1):D211-D221. PMC: 8728130. DOI: 10.1093/nar/gkab808. View

Kozomara A, Birgaoanu M, Griffiths-Jones S . miRBase: from microRNA sequences to function. Nucleic Acids Res. 2018; 47(D1):D155-D162. PMC: 6323917. DOI: 10.1093/nar/gky1141. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Tsuchiya N, Sawada Y, Endo I, Saito K, Uemura Y, Nakatsura T . Biomarkers for the early diagnosis of hepatocellular carcinoma. World J Gastroenterol. 2015; 21(37):10573-83. PMC: 4588079. DOI: 10.3748/wjg.v21.i37.10573. View

Wang Z, Gerstein M, Snyder M . RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet. 2008; 10(1):57-63. PMC: 2949280. DOI: 10.1038/nrg2484. View

Hishida A, Yamada H, Ando Y, Okugawa Y, Shiozawa M, Miyagi Y . Investigation of miRNA expression profiles using cohort samples reveals potential early detectability of colorectal cancers by serum miR-26a-5p before clinical diagnosis. Oncol Lett. 2022; 23(3):87. PMC: 8805182. DOI: 10.3892/ol.2022.13207. View

Colaprico A, C Silva T, Olsen C, Garofano L, Cava C, Garolini D . TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2015; 44(8):e71. PMC: 4856967. DOI: 10.1093/nar/gkv1507. View

Dai D, Li Y, Chen B, Du Y, Li S, Lu S . Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis. J Mol Med (Berl). 2017; 95(8):873-886. PMC: 5515997. DOI: 10.1007/s00109-017-1537-1. View

Jiang J, Liu H, Liu Z, Tan S, Wu B . Identification of cystatin SN as a novel biomarker for pancreatic cancer. Tumour Biol. 2015; 36(5):3903-10. DOI: 10.1007/s13277-014-3033-3. View

10.

Ostrom Q, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y . CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro Oncol. 2013; 15 Suppl 2:ii1-56. PMC: 3798196. DOI: 10.1093/neuonc/not151. View

11.

Heath A, Ferretti V, Agrawal S, An M, Angelakos J, Arya R . The NCI Genomic Data Commons. Nat Genet. 2021; 53(3):257-262. DOI: 10.1038/s41588-021-00791-5. View

12.

Rico S, Schliesser S, Gorbokon N, Dum D, Menz A, Buscheck F . Pattern of MUC6 expression across 119 different tumor types: A tissue microarray study on 15 412 tumors. Pathol Int. 2023; 73(7):281-296. PMC: 11551819. DOI: 10.1111/pin.13322. View

13.

Sun B, Huang Z, Wang B, Yu Y, Lin S, Luo L . Significance of Glypican-3 (GPC3) Expression in Hepatocellular Cancer Diagnosis. Med Sci Monit. 2017; 23:850-855. PMC: 5325041. DOI: 10.12659/msm.899198. View

14.

Gusyatiner O, Hegi M . Glioma epigenetics: From subclassification to novel treatment options. Semin Cancer Biol. 2017; 51:50-58. DOI: 10.1016/j.semcancer.2017.11.010. View

15.

Xu F, Wang Y, Ling Y, Zhou C, Wang H, Teschendorff A . dbDEMC 3.0: Functional Exploration of Differentially Expressed miRNAs in Cancers of Human and Model Organisms. Genomics Proteomics Bioinformatics. 2022; 20(3):446-454. PMC: 9801039. DOI: 10.1016/j.gpb.2022.04.006. View

16.

Pendas-Franco N, Garcia J, Pena C, Valle N, Palmer H, Heinaniemi M . DICKKOPF-4 is induced by TCF/beta-catenin and upregulated in human colon cancer, promotes tumour cell invasion and angiogenesis and is repressed by 1alpha,25-dihydroxyvitamin D3. Oncogene. 2008; 27(32):4467-77. DOI: 10.1038/onc.2008.88. View

17.

Zhang X, Li Z, Xuan Z, Xu P, Wang W, Chen Z . Novel role of miR-133a-3p in repressing gastric cancer growth and metastasis via blocking autophagy-mediated glutaminolysis. J Exp Clin Cancer Res. 2018; 37(1):320. PMC: 6302516. DOI: 10.1186/s13046-018-0993-y. View

18.

Xia M, Liu C, Zhang Q, Guo A . GEDS: A Gene Expression Display Server for mRNAs, miRNAs and Proteins. Cells. 2019; 8(7). PMC: 6678772. DOI: 10.3390/cells8070675. View

19.

Han S, Ding X, Wang S, Xu L, Li W, Sun W . miR-133a-3p Regulates Hepatocellular Carcinoma Progression Through Targeting CORO1C. Cancer Manag Res. 2020; 12:8685-8693. PMC: 7519587. DOI: 10.2147/CMAR.S254617. View

20.

Kavakiotis I, Alexiou A, Tastsoglou S, Vlachos I, Hatzigeorgiou A . DIANA-miTED: a microRNA tissue expression database. Nucleic Acids Res. 2021; 50(D1):D1055-D1061. PMC: 8728140. DOI: 10.1093/nar/gkab733. View